A new Northwestern Drugs multi-specialty clinic is boosting accessibility to significant-excellent subspecialty treatment in the south suburbs. The 5,523-sq.-foot clinic, positioned in Suite 210, Northwestern Medicine Orland Park, 15300 West Avenue, is now offering neurology companies. Esophageal and hepatology subspecialties will be added this summer time.
“One particular of the most important rewards of this multi-specialty clinic is the seamless integration into the relaxation of the Northwestern Medicine method,” says Neuro-oncologist and Neurology Regional Ambulatory Director Rimas V. Lukas, MD. “With the properly-proven framework at Orland Park, our group is thrilled to focus on further more acquiring require-based specialties and identifying what supplemental products and services are most valuable to this patient population.”
As portion of the broader Northwestern Medicine expansion and medical integration system, the new clinic will supply entry to Northwestern Memorial Hospital’s top rated-ranked neurology software, together with fellowship-properly trained experts in epilepsy, movement diseases, headache, rest well being, many sclerosis, neuromuscular and extra. Neurologists in Orland Park will collaborate intently with the Neurosurgery workforce at Northwestern Medicine Palos Hospital, which is also increasing.
Stephan U. Schuele, MD, head of the Epilepsy Division at Northwestern Drugs, suggests the clinic will give an a lot easier entrance to subspecialty companies for individuals in south suburban communities. “The people I see with chronic epilepsy usually can not generate, and patients with seizures typically want care extra immediately,” claims Dr. Schuele. “This clinic will allow for us to present a extra obtainable epilepsy method in the south suburbs, whereby these sufferers can now be seen by Northwestern Medication professionals who provide world-class care.”
Continued Development at Northwestern Drugs Orland Park
To complement existing and typical gastroenterology choices in the south suburbs, esophageal and hepatology subspecialties will be offered at the new clinic in the coming months.
“Data supports that general survival in patients with stop-phase liver sickness, for illustration, is immediately connected to proximity to treatment,” claims Standard Hepatologist and Transplant Hepatologist Justin R. Boike, MD. “By bringing esophageal and hepatology subspecialty treatment nearer to this inhabitants of patients, we can help to eliminate just one of the largest logistical worries to acquiring care that can improve patient outcomes.